Study of NC-4016 in Patients With Advanced Solid Tumors or Lymphoma
Status:
Completed
Trial end date:
2017-04-01
Target enrollment:
Participant gender:
Summary
The goal of this clinical research study is to find the highest tolerated dose of NC-4016
that can be given to patients with advanced solid tumors or lymphoma. The safety of the drug
will also be studied.